Skip to content

Study title and acronym: INcreasing the upTakE of IPTp-SP throuGh Seasonal MalaRiA ChemoprevenTION channel delivery - INTEGRATION

INCREASING THE UPTAKE OF INTERMITTENT PREVENTIVE TREATMENT USING SULFADOXINE-PYRIMETHAMINE THROUGH SEASONAL MALARIA CHEMOPREVENTION CHANNEL DELIVERY

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202208844472053
Enrollment
1974
Registered
2022-08-11
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Interventions

Delivery of IPTp SP through the seasonal malaria chemoprevention channel
Delivery of IPTp SP through seasonal malaria chemoprevention channel

Sponsors

University of Sciences Techniques and Technologies of Bamako
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women aged 15-49 years in their 2nd or 3rd trimester in a trial facility Women who delivered in the last 12 months Health providers providing ANC services in a trial facility SMC staff and CHWs/CR delivering SMC in the community Guardians of children receiving SMC in the catchment areas of trial facilities Health managers at the facility, district, and national levels in the Ministry of Health

Exclusion criteria

Exclusion criteria: Pregnant women participating in the household survey Women not consenting to participate Known pregnant women who are HIV-positive

Design outcomes

Primary

MeasureTime frame
The proportion of women who delivered within the last 12 months who received at least 3 doses of IPTp-SP during pregnancy.

Secondary

MeasureTime frame
Proportion of recently pregnant women who received 0, 1, 2 doses of IPTp-SP during their last pregnancy Proportion of recently pregnant women who attended 1, 2, 3, 4, 5, 6, 7, and 8 antenatal visits (or contacts) during their last pregnancy ;Proportion of children reached by SMC ;Proportion of women who attended ANC after the first trimester and were eligible for IPTp, but who did not receive SP;Proportion of doses of IPTp-SP given by Directly Observed Therapy (DOT) ;Mean gestational age at first ANC visit and at first IPTp-SP administration ;Incidence of malaria in children and pregnant women and incidence of birth outcomes at delivery (health center records).;Marginal economic cost per woman receiving correct number of doses of IPTp-SP in the intervention, versus control arm.;Marginal economic cost per DALY averted in intervention, versus control arm.;Acceptability and feasibility of ANC + SMC combined delivery of IPTp-SP compared to standard care (ANC) among health providers.;Acceptability of ANC + SMC combined delivery of IPTp-SP compared to standard care (ANC) among pregnant women.

Countries

Burkina Faso, Mali

Contacts

Public ContactKadiatou Koita

Liverpool School of Tropical Medicine

kadiatou.koita@lstmed.ac.uk+4084497773

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026